Jeffrey Cohen, MD: Understanding Pathways, Treatments for Lichenoid Dermatoses
This segment of Cohen’s interview from AAD covered the other talk given by Cohen titled ‘Knowing Lichenoid Dermatoses: Common Pathways and Treatments.’
Stay updated with breaking news from Lichen Planus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This segment of Cohen’s interview from AAD covered the other talk given by Cohen titled ‘Knowing Lichenoid Dermatoses: Common Pathways and Treatments.’
The changes in the tongue's normal appearance are linked to the function of various vital organs, which provide clues about what is going on within our overall health.
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, discusses unique challenges dermatologists face when treating patients with skin of color, who may present differently from White patients.
/PRNewswire/ -- Lipella Pharmaceuticals Inc. (Nasdaq: "LIPO") ("Lipella," "our, "us" or the "Company"), a clinical-stage biotechnology company addressing...
Cutaneous immune-related adverse events are associated with a better prognosis among patients with cancer who receive immune checkpoint inhibitors, new research suggests.